STRUCTURE-ACTIVITY-RELATIONSHIPS OF RETINOIDS IN DEVELOPMENTAL TOXICOLOGY .4. PLANAR CISOID CONFORMATIONAL RESTRICTION

被引:25
作者
WILLHITE, CC [1 ]
DAWSON, MI [1 ]
机构
[1] SRI INT, BIOORGAN CHEM LAB, MENLO PK, CA 94025 USA
关键词
D O I
10.1016/0041-008X(90)90233-K
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
To evaluate the influence of the three-dimensional configuration of retinoids on teratogenic activity, 14 retinoids were studied in hamsters. Retinoids with a conformational restriction of the retinoic acid polyene chain adjacent to the β-cyclogeranylidene ring showed increased teratogenic potency and retinoids with aromatic conformational restriction adjacent to the polar terminus showed potency equivalent to retinoic acid. Conformational restriction of the polyene chain that permits rotation of the bond adjacent to the β-cyclogeranylidene ring abolished teratogenic activity. Incorporation of dimethyl substituents at positions corresponding to C1 and C4 positions of retinoic acid enhanced teratogenic potency. Elimination of the twist chair conformation of gem-dimethyl substituents via incorporation of a benzothiopyran or substituted planar aromatic ring decreased teratogenic potency. Planar cisoid conformational restriction alone was insufficient to confer teratogenic activity in that elimination of the polar terminus abolished teratogenic activity. That an acidic polar terminus, as contrasted to a carboxyl residue per se, was required for teratogenic activity was illustrated by administration of a retinoidal phenyl sulfone which was metabolized to the corresponding teratogenic sulfonic acid. Retinoid teratogenicity in hamsters depends upon the assumption of a 10,11 cisoid and/or 12,13 cisoid rotameric form by a conjugated spacer greater than five carbon atoms in length located between a hydrophobic ring system and an acidic terminus, ionized at physiologic pH. Comparison of the relative teratogenic potencies of this series of conformationally restricted retinoids with their activities in assays for chemoprevention activity showed that those analogs with high intrinsic control of epithelial or mesenchymal cell differentiation were also the more potent teratogens. The results suggest that those biochemical mechanisms responsible for retinoid control of normal adult or neoplastic cell differentiation also mediate retinoid-induced teratogenesis. © 1990.
引用
收藏
页码:324 / 344
页数:21
相关论文
共 52 条
[1]   EXTENT OF FETAL OSSIFICATION AS AN INDEX OF DELAYED DEVELOPMENT IN TERATOGENIC STUDIES ON THE RAT [J].
ALIVERTI, V ;
BONANOMI, L ;
GIAVINI, E ;
LEONE, VG ;
MARIANI, L .
TERATOLOGY, 1979, 20 (02) :237-242
[2]   HISTOLOGIC-CHANGES IN THE SKIN OF THE RHINO MOUSE (HRRHHRRH) INDUCED BY RETINOIDS [J].
ASHTON, RE ;
CONNOR, MJ ;
LOWE, NJ .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1984, 82 (06) :632-635
[3]  
BOLLAG W, 1985, RETINOIDS NEW TRENDS, P274
[4]  
CONNOR MJ, 1986, J PHARMACOL EXP THER, V237, P31
[5]   CONFORMATIONALLY RESTRICTED RETINOIDS [J].
DAWSON, MI ;
HOBBS, PD ;
DERDZINSKI, K ;
CHAN, RLS ;
GRUBER, J ;
CHAO, WR ;
SMITH, S ;
THIES, RW ;
SCHIFF, LJ .
JOURNAL OF MEDICINAL CHEMISTRY, 1984, 27 (11) :1516-1531
[6]   SYNTHESIS AND PHARMACOLOGICAL ACTIVITY OF 6-[(E)-2-(2,6,6-TRIMETHYL-1-CYCLOHEXEN-1-YL)ETHEN-1-YL] AND 6-(1,2,3,4-TETRAHYDRO-1,1,4,4-TETRAMETHYL-6-NAPHTHYL)-2-NAPHTHALENECARBOXYLIC ACIDS [J].
DAWSON, MI ;
CHAN, RLS ;
DERDZINSKI, K ;
HOBBS, PD ;
CHAO, WR ;
SCHIFF, LJ .
JOURNAL OF MEDICINAL CHEMISTRY, 1983, 26 (11) :1653-1656
[7]   AROMATIC RETINOIC ACID ANALOGS .2. SYNTHESIS AND PHARMACOLOGICAL ACTIVITY [J].
DAWSON, MI ;
CHAN, R ;
HOBBS, PD ;
CHAO, WR ;
SCHIFF, LJ .
JOURNAL OF MEDICINAL CHEMISTRY, 1983, 26 (09) :1282-1293
[8]   EFFECT OF STRUCTURAL MODIFICATIONS IN THE C7-C11 REGION OF THE RETINOID SKELETON ON BIOLOGICAL-ACTIVITY IN A SERIES OF AROMATIC RETINOIDS [J].
DAWSON, MI ;
HOBBS, PD ;
DERDZINSKI, KA ;
CHAO, WR ;
FRENKING, G ;
LOEW, GH ;
JETTEN, AM ;
NAPOLI, JL ;
WILLIAMS, JB ;
SANI, BP ;
WILLE, JJ ;
SCHIFF, LJ .
JOURNAL OF MEDICINAL CHEMISTRY, 1989, 32 (07) :1504-1517
[9]  
FLANAGAN JL, 1987, JNCI-J NATL CANCER I, V78, P533
[10]  
FRITSCH P, 1984, RETINOID THERAPY REV, P329